Last reviewed · How we verify
Colpormon (hydroxyestrone diacetate)
Colpormon (generic name: hydroxyestrone diacetate) is a drug. It is currently in unknown development.
Colpormon works by interacting with estrogen receptors in the body, potentially influencing various physiological processes.
Colpormon is a synthetic, steroidal estrogen that has been marketed in several countries, including France, Spain, Brazil, and Argentina. It is a derivative of 16α-hydroxyestrone with acetate esters attached at the C3 and C16α positions.
At a glance
| Generic name | hydroxyestrone diacetate |
|---|---|
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine estrogen as a key that unlocks specific doors in your cells. Colpormon is a modified version of this key that can fit into those doors and potentially change how they work. This could affect various bodily functions, such as growth and development, but the exact effects are still unknown.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Colpormon CI brief — competitive landscape report
- Colpormon updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Colpormon
What is Colpormon?
How does Colpormon work?
What is the generic name of Colpormon?
What development phase is Colpormon in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing